Search company, investor...

Sequel Pharmaceuticals

Founded Year



Dead | Dead

Total Raised


About Sequel Pharmaceuticals

Sequel Pharmaceuticals is a product-focused pharmaceutical company involved in cardiovascular drug development primarily focused on developing and commercializing clinical-stage drug candidates.

Headquarters Location

12750 High Bluff Drive Suite 300

San Diego, California, 92130,

United States


Missing: Sequel Pharmaceuticals's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Sequel Pharmaceuticals's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Sequel Pharmaceuticals Frequently Asked Questions (FAQ)

  • When was Sequel Pharmaceuticals founded?

    Sequel Pharmaceuticals was founded in 2007.

  • Where is Sequel Pharmaceuticals's headquarters?

    Sequel Pharmaceuticals's headquarters is located at 12750 High Bluff Drive, San Diego.

  • What is Sequel Pharmaceuticals's latest funding round?

    Sequel Pharmaceuticals's latest funding round is Dead.

  • How much did Sequel Pharmaceuticals raise?

    Sequel Pharmaceuticals raised a total of $24.4M.

  • Who are the investors of Sequel Pharmaceuticals?

    Investors of Sequel Pharmaceuticals include InterWest Partners, Skyline Ventures, Forward Ventures, Montreux Equity Partners and Domain Associates.

  • Who are Sequel Pharmaceuticals's competitors?

    Competitors of Sequel Pharmaceuticals include Arena Pharmaceuticals, Diffusion Pharmaceuticals, Pulmatrix, Omthera Pharmaceuticals, Supernus Pharmaceuticals and 11 more.

Compare Sequel Pharmaceuticals to Competitors

IVREA Pharmaceuticals

IVREA Pharmaceuticals is a specialty pharmaceutical company focused on clinical development and commercialization of novel prescription pharmaceuticals for the treatment of dermatologic conditions. IVREA's pharmaceuticals leverage topical delivery technologies.

Advent Pharmaceuticals

Advent Pharmaceuticals is a specialty pharmaceutical company focused on developing inhaled drug products using a dry powder inhalation delivery system. The products are mostly used for the treatment of asthma and other respiratory diseases.

Verva Pharmaceuticals

Verva Pharmaceuticals is an exciting, clinical-stage pharmaceutical company focused on the discovery and development of therapies to treat metabolic diseases (formerly Adipogen).

Piedmont Pharmaceuticals

Piedmont is a specialty pharmaceutical company focused on human and animal health therapeutics with expertise in parasitology and drug delivery systems.

Kytogenics Pharmaceuticals Limited

Kytogenics is a medical device company. It had developed the Nocc Hydrophilic Wound Dressing.Kytogenics Pharmaceuticals, Inc. is a biomedical company engaged in the development of products based on its medical device and drug delivery patented platform technology.


Terapio is a biopharmaceutical company specializing in the development of a pipeline of therapies based on the transport protein, RLIP76.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.